![Thomas Bures](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Bures
Comptroller/Controller/Auditor at BRUKER CORPORATION
Net worth: 194 241 $ as of 2025-11-29
Profile
Mr. Thomas Bures is a Chief Accounting Officer at Bruker Corp.
Mr. Bures was previously employed as a Senior VP, Chief Financial & Accounting Officer by Pieris Pharmaceuticals, Inc., a Vice President & Controller by Genocea Biosciences, Inc., and a Vice President & Assistant Controller by PAREXEL International Corp.
He received his undergraduate degree from the College of the Holy Cross (Massachusetts).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-03-09 | 3,472 ( 0% ) | 169 468 $ | 2025-11-29 | |
0% | 2024-10-31 | 241 ( 0% ) | 24 772 $ | 2025-11-29 |
Latest news about Thomas Bures
Thomas Bures active positions
| Companies | Position | Start |
|---|---|---|
| BRUKER CORPORATION | Comptroller/Controller/Auditor | 2025-01-12 |
Former positions of Thomas Bures
| Companies | Position | End |
|---|---|---|
| PIERIS PHARMACEUTICALS | Director of Finance/CFO | 2024-12-12 |
| GENOCEA BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 2017-11-30 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Training of Thomas Bures
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization and provides insights-driven clinical and consulting solutions | Health Technology |
Bruker Corp.
 Bruker Corp. Medical SpecialtiesHealth Technology Manufactures analytical and medical instruments | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel vaccines | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. Develops and markets an anticalin-brand protein technology |
- Stock Market
- Insiders
- Thomas Bures
